Skip to main content

Find Clinical Trials

Home
Conditions
t(8;21)

Clinical trial condition

t(8;21)

Explore clinical trials studying t(8;21). Study availability and eligibility vary by location and protocol.

2 public trials 1 recruiting study

Refine in advanced search Browse all conditions

t(8;21) trial results

Recruiting

Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

NCT00801489

Conditions: Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11, Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11, Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1, +19 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Enrolling by Invitation

Treatment of Relapsed or Refractory t(8; 21) AML With Targeted AML1-ETO Neoantigen Cytotoxic T Cells (CTL)

NCT06499025

Conditions: AML, Neoantigen, t(8;21)
Locations: Shenzhen University General Hospital Shenzhen, Guangdong, China

View Trial Details